Zhang Robert S, Yuriditsky Eugene, Zhang Peter, Taslakian Bedros, Elbaum Lindsay, Greco Allison A, Mukherjee Vikramjit, Postelnicu Radu, Amoroso Nancy E, Maldonado Thomas S, Horowitz James M, Bangalore Sripal
Division of Cardiology, Weill Cornell Medicine, New York, NY (R.S.Z.).
Division of Cardiovascular Medicine (E.Y., L.E., J.M.H., S.B.), New York University.
Circ Cardiovasc Interv. 2025 Jan;18(1):e014499. doi: 10.1161/CIRCINTERVENTIONS.124.014499. Epub 2025 Jan 21.
The aim of this study was to examine the impact of early versus delayed catheter-based therapies (CBTs) on clinical outcomes in patients with acute intermediate-risk pulmonary embolism (PE).
This retrospective cohort study analyzed data from 2 academic centers involving patients with intermediate-risk PE from January 2020 to January 2024. Patients were divided into early (<12 hours) and delayed CBT (≥12 hours) groups. The primary outcome was a composite of 30-day mortality, resuscitated cardiac arrest, hemodynamic instability, and 90-day readmission. Secondary outcomes included a composite of 30-day mortality, resuscitated cardiac arrest, and hemodynamic instability. Inverse probability of treatment weighting was used to balance covariates.
A total of 133 patients were included (mean age, 58.3 years; 44% women; 29% catheter-directed thrombolysis; 68% mechanical thrombectomy; and 3% both). The median time to intervention was 6.1 hours in the early group and 20.8 hours in the delayed group (<0.001). A total of 16 patients (12% of patients) experienced the primary composite outcome. Early CBT was associated with a significantly lower rate of the primary composite outcome (4% versus 18%; log-rank <0.001; inverse probability of treatment weighting [hazard ratio, 0.13 (95% CI, 0.03-0.58); =0.007]) and secondary composite outcome (0% versus 9%; log-rank =0.02). The early CBT group also had lower intensive care unit (3.0 versus 3.4 days; =0.01) and hospital length of stay (5.0 versus 6.1 days; =0.046). When patients were stratified by timing of CBT (early/late) and the composite PE shock score (high ≥3; low <3), all 16 patients who experienced the primary composite outcome had a high composite PE shock score, with 14/16 (87.5%) having a high composite PE shock score and delayed intervention.
Early CBT was associated with improved clinical outcomes in patients with acute intermediate-risk PE. The composite PE shock score may help identify patients who will benefit from early CBT. Further prospective studies are needed to validate these findings.
本研究旨在探讨早期与延迟导管介入治疗(CBT)对急性中危肺栓塞(PE)患者临床结局的影响。
这项回顾性队列研究分析了2个学术中心2020年1月至2024年1月期间中危PE患者的数据。患者分为早期(<12小时)和延迟CBT(≥12小时)组。主要结局是30天死亡率、心脏骤停复苏、血流动力学不稳定和90天再入院的复合结局。次要结局包括30天死亡率、心脏骤停复苏和血流动力学不稳定的复合结局。采用治疗权重逆概率法平衡协变量。
共纳入133例患者(平均年龄58.3岁;44%为女性;29%接受导管直接溶栓;68%接受机械血栓清除术;3%两者均接受)。早期组的中位干预时间为6.1小时,延迟组为20.8小时(<0.001)。共有16例患者(占患者总数的12%)出现主要复合结局。早期CBT与主要复合结局发生率显著降低相关(4%对18%;对数秩检验<0.001;治疗权重逆概率法[风险比,0.13(95%CI,0.03 - 0.58);P = 0.007]),次要复合结局发生率也显著降低(0%对9%;对数秩检验P = 0.02)。早期CBT组的重症监护病房住院时间(3.0天对3.4天;P = 0.01)和住院总时长(5.0天对6.1天;P = 0.046)也较短。当根据CBT时机(早期/晚期)和复合PE休克评分(高≥3;低<3)对患者进行分层时,所有16例出现主要复合结局的患者复合PE休克评分均为高,其中14/16(87.5%)复合PE休克评分高且干预延迟。
早期CBT与急性中危PE患者临床结局改善相关。复合PE休克评分可能有助于识别将从早期CBT中获益的患者。需要进一步的前瞻性研究来验证这些发现。